Literature DB >> 24111845

Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation.

Mia Moberg1, Jørgen Vestbo, Gerd Martinez, Johanna E A Williams, Steen Ladelund, Peter Lange, Thomas Ringbaek.   

Abstract

Abstract The aim of this study was to examine the value of the i-BODE index to predict hospital admission and to confirm its usefulness to predict mortality in a Danish population. The incremental shuttle walking test (ISWT) is widely used in the UK and Europe and previous work has examined the replacement of the 6MWT with the ISWT within the BODE index for predicting the prognosis of COPD (i-BODE). The 674 patients included in the analysis participated in a 7-week pulmonary rehabilitation program from 2002 to 2011. The National Health Services Central Register ascertained vital status and provided information on all hospital admissions. The mean follow-up period was 66 months (range 11-118 months). Cox proportional hazards model was used to identify factors that significantly predicted mortality and time to first hospital admission. The i-BODE index as well as body mass index, MRC dyspnea grade, and exercise capacity (ISWT) were significantly associated with all-cause mortality. The adjusted hazard ratio for death per one point increase in the i-BODE score was 1.28 (95% confidence interval 1.20 to 1.37). The i-BODE index was also a significant predictor of hospitalization, both for all causes and COPD exacerbation. Patients in the highest i-BODE quartile had a median time to first hospitalization of 17 months compared to 51 months for patients in the lowest quartile. The i-BODE index is a significant predictor of hospital admission and thus health care utilization, and also mortality.

Entities:  

Keywords:  BODE Index; Incremental Shuttle Walking Test; exercise test; survival

Mesh:

Year:  2013        PMID: 24111845     DOI: 10.3109/15412555.2013.836171

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  10 in total

1.  Machine Learning and Prediction of All-Cause Mortality in COPD.

Authors:  Matthew Moll; Dandi Qiao; Elizabeth A Regan; Gary M Hunninghake; Barry J Make; Ruth Tal-Singer; Michael J McGeachie; Peter J Castaldi; Raul San Jose Estepar; George R Washko; James M Wells; David LaFon; Matthew Strand; Russell P Bowler; MeiLan K Han; Jorgen Vestbo; Bartolome Celli; Peter Calverley; James Crapo; Edwin K Silverman; Brian D Hobbs; Michael H Cho
Journal:  Chest       Date:  2020-04-27       Impact factor: 9.410

2.  A Multidimensional Risk Score to Predict All-Cause Hospitalization in Community-Dwelling Older Individuals With Obstructive Lung Disease.

Authors:  Rosanne J H C G Beijers; Bram van den Borst; Anne B Newman; Sachin Yende; Stephen B Kritchevsky; Patricia A Cassano; Douglas C Bauer; Tamara B Harris; Annemie M W J Schols
Journal:  J Am Med Dir Assoc       Date:  2016-02-23       Impact factor: 4.669

3.  Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit.

Authors:  Mamta Ruparel; Jose Luis López-Campos; Ady Castro-Acosta; Sylvia Hartl; Francisco Pozo-Rodriguez; C Michael Roberts
Journal:  ERJ Open Res       Date:  2016-03-05

4.  Predictors of mortality in patients with COPD after 9 years.

Authors:  Robson Prudente; Estefânia Aparecida Thomé Franco; Carolina Bonfanti Mesquita; Renata Ferrari; Irma de Godoy; Suzana Erico Tanni
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-17

5.  Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort.

Authors:  Christopher B Cooper; Robert Paine; Jeffrey L Curtis; Richard E Kanner; Carlos H Martinez; Catherine A Meldrum; Russell Bowler; Wanda O'Neal; Eric A Hoffman; David Couper; Miguel Quibrera; Gerald Criner; Mark T Dransfield; MeiLan K Han; Nadia N Hansel; Jerry A Krishnan; Stephen C Lazarus; Stephen P Peters; R Graham Barr; Fernando J Martinez; Prescott G Woodruff
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-04

6.  A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study.

Authors:  Matthew Strand; Erin Austin; Matthew Moll; Katherine A Pratte; Elizabeth A Regan; Lystra P Hayden; Surya P Bhatt; Aladin M Boriek; Richard Casaburi; Edwin K Silverman; Spyridon Fortis; Ingo Ruczinski; Harald Koegler; Harry B Rossiter; Mariaelena Occhipinti; Nicola A Hanania; Hirut T Gebrekristos; David A Lynch; Ken M Kunisaki; Kendra A Young; Jessica C Sieren; Margaret Ragland; John E Hokanson; Sharon M Lutz; Barry J Make; Gregory L Kinney; Michael H Cho; Massimo Pistolesi; Dawn L DeMeo; Frank C Sciurba; Alejandro P Comellas; Alejandro A Diaz; Igor Barjaktarevic; Russell P Bowler; Richard E Kanner; Stephen P Peters; Victor E Ortega; Mark T Dransfield; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2020-10

7.  Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease.

Authors:  Xin Zhang; Lijie Liu; Rui Liang; Shoude Jin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-26

8.  The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life.

Authors:  Roberto W Dal Negro; Bartolome R Celli
Journal:  Multidiscip Respir Med       Date:  2016-03-03

9.  Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).

Authors:  Jasvinder A Singh; Shaohua Yu
Journal:  Respir Res       Date:  2016-01-06

10.  Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study.

Authors:  Josep Montserrat-Capdevila; Pere Godoy; Josep Ramon Marsal; Ferran Barbé; Leonardo Galván
Journal:  BMC Fam Pract       Date:  2015-12-08       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.